The kinetics of salivary elimination of cyclophosphamide in man.
dc.contributor.author | Juma, FD | |
dc.contributor.author | Rogers, HJ | |
dc.contributor.author | Trounce, JR | |
dc.date.accessioned | 2013-04-29T07:53:15Z | |
dc.date.available | 2013-04-29T07:53:15Z | |
dc.date.issued | 1979 | |
dc.identifier.citation | Br J Clin Pharmacol. 1979 Nov;8(5):455-8 | en |
dc.identifier.uri | http://hinari-gw.who.int/whalecomwww.ncbi.nlm.nih.gov/whalecom0/pubmed/508550 | |
dc.identifier.uri | http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/17465 | |
dc.description.abstract | The concentrations of cyclophosphamide in plasma and saliva were determined in seven patients following administration of single doses of cyclophosphamide during chemotherapy for lymphoma. 2 The saliva/plasma ratio was 0.77 +/- 0.24 (s.d.) and showed no time-dependence being rapidly established following intravenous and oral administration. 3 The T 1/2 of cyclophosphamide (8.38 +/- 2.25 h) determined from salivary measurements was not significantly different from that in plasma (8.24 +/- 2.60 h). It was not possible to estimate the apparent volume of distribution or total body clearance utilizing the salivary cyclophosphamide concentration without appropriate correction for the saliva/plasma concentration ratio. 4 The binding to the plasma protein of normal plasma of cyclophosphamide was 13.4 +/- 5.3%. The Scatchard plot for binding to bovine serum albumin indicates only weak binding to non-specific sites. 5 Salivary cyclophosphamide therefore indicates the concentration of the unbound fraction of plasma cyclophosphamide. | en |
dc.language.iso | en | en |
dc.title | The kinetics of salivary elimination of cyclophosphamide in man. | en |
dc.type | Article | en |
Files in this item
This item appears in the following Collection(s)
-
Faculty of Health Sciences (FHS) [10378]